Overexpression of gremlin-1 in patients with Loeys-Dietz syndrome: Implications on pathophysiology and early disease detection

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Wellbrock, Jasmin ^a   Sheikhzadeh, Sara ^a   Oliveira Ferrer, Leticia ^a   Stamm, Hauke ^a   Hillebrand, Mathias ^a   Keyser, Britta ^b   Klokow, Marianne ^a   Vohwinkel, Gabi ^a   Bonk, Veronika ^a   Otto, Benjamin ^a   Streichert, Thomas ^a   Balabanov, Stefan ^a,c   Hagel, Christian ^a   Rybczynski, Meike ^a   Bentzien, Frank ^a   Bokemeyer, Carsten ^a   Von Kodolitsch, Yskert ^a   Fiedler, Walter ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BMP2 PROTEIN, HUMAN; BMP4 PROTEIN, HUMAN; BMPR1A PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; GREM1 PROTEIN, HUMAN; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; LTBP1 PROTEIN, HUMAN; MESSENGER RNA; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TGF-BETA TYPE I RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR;

ADULT; AORTA; BIOSYNTHESIS; CELL PROLIFERATION; EARLY DIAGNOSIS; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LOEYS-DIETZ SYNDROME; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR SMOOTH MUSCLE; YOUNG ADULT;

ADULT; AORTA; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CELL PROLIFERATION; EARLY DIAGNOSIS; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LATENT TGF-BETA BINDING PROTEINS; LOEYS-DIETZ SYNDROME; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; YOUNG ADULT;

EID: 84905851461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104742     Document Type: Article

References (35)

1. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, et al. (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275-281. (Pubitemid 41716254)
2. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, et al. (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355:788-798. (Pubitemid 44285584)
3. Stheneur C, Collod-Beroud G, Faivre L, Gouya L, Sultan G, et al. (2008) Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders. Hum Mutat 29:E284-295.
4. Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, et al. (2012) Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 44:922-927.
5. van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, et al. (2011) Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43:121-126.
6. Van Laer L, Dietz H, Loeys B (2014) Loeys-dietz syndrome. Adv Exp Med Biol 802:95-105.
7. Otten J, Bokemeyer C, Fiedler W (2010) Tgf-Beta superfamily receptors-targets for antiangiogenic therapy? J Oncol 2010:317068.
8. Pugsley MK, Tabrizchi R (2000) The vascular system. An overview of structure and function. J Pharmacol Toxicol Methods 44:333-340. (Pubitemid 32452198)
9. Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D'Amore PA (1999) Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 84:298-305. (Pubitemid 29095570)
10. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, et al. (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104:2752-2760. (Pubitemid 39434958)
11. Fernandez LA, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Hebbel RP, et al. (2005) Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res 68:235-248. (Pubitemid 41428420)
12. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, et al. (2009) Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 37:e67.
13. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
14. Sauna ZE, Kimchi-Sarfaty C (2011) Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12:683-691.
15. Maleszewski JJ, Miller DV, Lu J, Dietz HC, Halushka MK (2009) Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS). Am J Surg Pathol 33:194-201.
16. Denton CP, Zheng B, Evans LA, Shi-wen X, Ong VH, et al. (2003) Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice. J Biol Chem 278:25109-25119. (Pubitemid 37548675)
17. Graham JR, Williams CM, Yang Z (2014) MicroRNA-27b Targets Gremlin 1 to Modulate Fibrotic Responses in Pulmonary Cells. J Cell Biochem.
18. Ma B, Kang Q, Qin L, Cui L, Pei C (2014) TGF-beta2 induces transdifferentiation and fibrosis in human lens epithelial cells via regulating gremlin and CTGF. Biochem Biophys Res Commun 447:689-695.
19. O'Reilly S, Ciechomska M, Cant R, van Laar JM (2014) Interleukin-6 (IL-6) trans signaling drives a STAT3-dependent pathway that leads to hyperactive transforming growth factor-beta (TGF-beta) signaling promoting SMAD3 activation and fibrosis via Gremlin protein. J Biol Chem 289:9952-9960.
20. Hsu DR, Economides AN, Wang X, Eimon PM, Harland RM (1998) The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1:673-683. (Pubitemid 128379245)
21. Topol LZ, Marx M, Laugier D, Bogdanova NN, Boubnov NV, et al. (1997) Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture. Mol Cell Biol 17:4801-4810. (Pubitemid 27318155)
22. Michos O, Panman L, Vintersten K, Beier K, Zeller R, et al. (2004) Gremlin-mediated BMP antagonism induces the epithelial-mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131:3401-3410. (Pubitemid 39139886)
23. McMahon R, Murphy M, Clarkson M, Taal M, Mackenzie HS, et al. (2000) IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J Biol Chem 275:9901-9904. (Pubitemid 30202033)
24. Zode GS, Clark AF, Wordinger RJ (2009) Bone morphogenetic protein 4 inhibits TGF-beta2 stimulation of extracellular matrix proteins in optic nerve head cells: role of gremlin in ECM modulation. Glia 57:755-766.
25. Smadja DM, Bieche I, Silvestre JS, Germain S, Cornet A, et al. (2008) Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol 28:2137-2143.
26. Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, et al. (2010) Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2. Blood 116:3677-3680.
27. Stabile H, Mitola S, Moroni E, Belleri M, Nicoli S, et al. (2007) Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood 109:1834-1840. (Pubitemid 46348177)
28. Wordinger RJ, Fleenor DL, Hellberg PE, Pang IH, Tovar TO, et al. (2007) Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma. Invest Ophthalmol Vis Sci 48:1191-1200. (Pubitemid 351261414)
29. Zhang Q, Shi Y, Wada J, Malakauskas SM, Liu M, et al. (2010) In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7. PLoS One 5:e11709.
30. Maciel TT, Melo RS, Schor N, Campos AH (2008) Gremlin promotes vascular smooth muscle cell proliferation and migration. J Mol Cell Cardiol 44:370-379.
31. Cahill E, Costello CM, Rowan SC, Harkin S, Howell K, et al. (2012) Gremlin plays a key role in the pathogenesis of pulmonary hypertension. Circulation 125:920-930.
32. Rabinovitch M (2008) Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 118:2372-2379.
33. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ, et al. (2004) Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res 68:75-103. (Pubitemid 39093882)
34. Matyas G, Arnold E, Carrel T, Baumgartner D, Boileau C, et al. (2006) Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders. Hum Mutat 27:760-769. (Pubitemid 44205069)
35. Biaggi P, Matthews F, Braun J, Rousson V, Kaufmann PA, et al. (2009) Gender, age, and body surface area are the major determinants of ascending aorta dimensions in subjects with apparently normal echocardiograms. J Am Soc Echocardiogr 22:720-725.